Loading...
| A02266 | Pages: 245 | Nov 2021 | 19056 Views | | |
| Author(s) : Shraddha Mali, Madhuvanti Divekar , Onkar Sumant | Tables: 136 | Charts: 30 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Medical Simulation Market
Request Now !The global medical simulation market size was valued at $1,687.50 million in 2020, and is projected to reach $6,688.60 million by 2030, registering a CAGR of 14.7% from 2021 to 2030. Medical simulation is a virtual replication of in-person actions or phenomena that represents the functions and qualities of a specific actual abstract or process. It is a type of simulation that is used to teach and train people in various medical professions. Simulations can take place in the classroom, or in real-world scenarios, or in the specifically built simulation locations.
Medical simulation is a training strategy in which healthcare workers use virtual reality or simulation models to practice activities and procedures in real-life scenarios. Rather to the apprentice style of learning, medical simulation allows for the methodical application of clinical skills. It can contain simulated human patients, artificial human patients, or a combination of the two, instructional materials with detailed simulated animations, casualty assessment in national security and war scenarios, emergency response, and holographic simulation to assist virtual health operations. Simulation tools can be used in place of actual patients.
Get more information on this report : Request Sample Pages
Simulation is a phrase used to describe an artificial representation of a real-world process that is utilized to achieve educational goals through experiential learning. Simulation-based medical education refers to any educational activity that includes simulation aides to mimic clinical conditions.
The growth in the use of medical simulation is mostly due to an increase in the use of simulation in healthcare; an increase in mortality as a result of medical mistakes; and the need to enhance patient safety outcomes are some of the reasons driving the medical simulation market expansion. Virtual and augmented reality are becoming more popular, and they have shown to be beneficial for teaching and communication in healthcare simulation programs. For example, virtual reality (VR) may be utilized to assist distant students in performing surgeries and other processes together. This enables students to put their knowledge into practice and improve their blunders. The use of virtual and augmented reality in healthcare simulation can be an excellent addition to hands-on training by conducting surgery and inserting IVs.
In addition, use of simulation for training healthcare professionals helps them gain confidence, knowledge, and expertise to improve patient safety. Thus, simulation provides an opportunity to better educate and train clinicians for improved patient safety outcomes and further minimize medical errors. With advent of simulation in professional education programs, clinical and critical thinking skills have increased for high risk, low frequency events. There are several simulators available in the market, which provide consistent, repeatable training, and exposure to a broader range of patients and scenarios besides normal clinical practice.
The medical field has witnessed various technological advancements, which, in turn, fuels the demand for simulation. Newly introduced medical devices and advanced procedures, such as Intra-Cardiac Echocardiography (ICE), cardiac assist devices, and mechanical ventilation enhancements require advanced training solutions such as simulation for internal product development and training.
However, the expensive cost of medical simulation is a key impediment to their widespread use. Most simulators used in the present scenario are expensive and require constant updates and maintenance services. In addition, operators need to be trained on using software and/or hardware, which requires additional time and money. Moreover, simulations require high amount of maintenance and may hinder the healthcare simulation market growth
The COVID-19 pandemic led to huge number of clinics and hospitals across the globe being restructured to increase the hospital capacity for patients diagnosed with COVID-19. The non-essential procedures took a potential backlog due to rapidly rising COVID-19 cases and had a negative impact on the market. The use of virtual simulation technologies was adopted during the pandemic to enhance and strengthen procedural and patient care skills. Further, increase in use of remote learning with the help of screen-based simulation, augmented reality/AR, mixed reality, blended and/or extended reality, and virtual reality/VR is expected to drive growth of the virtual medical simulation market.
Furthermore, opportunities in untapped, emerging markets with high potential, due to improved healthcare infrastructure, increase in unmet healthcare needs and rise in prevalence of medical errors in populations. Availability of various facilities providing such minimally invasive procedures is an emerging opportunity for the key players of the market to invest in the healthcare simulation market and thus will further accelerate the expansion of the market offering significant growth opportunities for the market during the forecast period.
The medical simulation market is segmented on the basis of product & service, fidelity, end user, and region. On the basis of product & service, it is divided into model-based simulation, web-based simulation, and simulation training services. The model-based simulation segment is further classified into patient simulation, surgical simulation, and ultrasound simulation. Moreover, patient simulation is segmented into task trainer simulation, manikin-based simulators, hybrid manikin-based simulation (with AR) and standardized patient simulators. Surgical simulation is divided in laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, orthopedic simulators, spine simulators, endovascular simulators and others. Furthermore, ultrasound simulation is segmented into anesthesia, cardiology, emergency medicine, intensive care unit, obstetrics & gynecology, radiology and others.
In addition, the web-based simulation segment is classified into simulation software, performance-recording software, virtual tutors and learning management software. The simulation training services segment comprise vendor-based training services, custom consulting services, and educational society.
On the basis of fidelity, the medical simulation market is classified into low fidelity, medium fidelity, and high fidelity simulators. By end user, it is divided into academic institutions, hospitals, and military organizations.
Region wise, the medical simulation market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Get more information on this report : Request Sample Pages
Depending on the product & service, model based simulation segment dominated the market in 2020, and is expected to continue this trend during the forecast period, due to rise in patient safety, rise in minimally invasive surgeries and limited access to live patients.
On the basis of fidelity, low fidelity segment led the market in 2020, and is expected to retain its dominance during the forecast period, owing to the simple usage and low cost.
By end user, academic institutions exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.
Get more information on this report : Request Sample Pages
North America accounted for a majority of the global medical simulation market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in medical errors, presence of key players, increase in healthcare expenditure, advancements in technology and rise in government initiatives in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to increase in overall population, surge in facilities offering medical simulation services and increased investments in healthcare sector in the region.
The key players operating in the global medical simulation market are CAE, Inc., Gaumard Scientific Company, Inc., Intelligent Ultrasound Group Plc., Kyoto Kagaku Co. Ltd., Laerdal Medical AS, Limbs and Things, Ltd., Mentice AB, Operative Experience, Inc., Simulab Corporation, and VirtaMed AG.
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
By Product & Services
By Fidelity
By End User
By Region
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profile in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in use of virtual and augmented reality
3.5.1.2.Assured improvement in patient safety outcomes
3.5.1.3.Benefits of medical simulation
3.5.1.4.Technological advancements in medical field
3.5.1.5.Increase in demand for virtual training
3.5.2.Restraints
3.5.2.1.High cost for setting up simulators
3.5.2.2.Limitation to imitate a complete real situation
3.5.3.Opportunity
3.5.3.1.Lucrative opportunities in emerging markets
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the medical simulation market
CHAPTER 4:GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE
4.1.Overview
4.1.1.Market size and forecast
4.2.Model-based simulation
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.4.1.Patient simulation
4.2.4.1.1.Market size and forecast
4.2.4.1.2.Manikin-based simulation
4.2.4.2.Surgical simulation
4.2.4.2.1.Market size and forecast
4.2.4.3.Ultrasound simulation
4.2.4.3.1.Market size and forecast
4.3.Web-based simulation
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.4.1.Simulation software
4.3.4.1.1.Market size and forecast
4.3.4.2.Performance recording software
4.3.4.2.1.Market size and forecast
4.3.4.3.Virtual tutors
4.3.4.3.1.Market size and forecast
4.3.4.4.Learning management software
4.3.4.4.1.Market size and forecast
4.4.Simulation training services
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.4.1.Vendor-based training
4.4.4.1.1.Market size and forecast
4.4.4.2.Custom consulting services
4.4.4.2.1.Market size and forecast
4.4.4.3.Educational societies
4.4.4.3.1.Market size and forecast
CHAPTER 5:GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY
5.1.Overview
5.1.1.Market size and forecast
5.2.Low-fidelity
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Medium-fidelity
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.High-fidelity
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:GLOBAL MEDICAL SIMULATION MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Academic institutions
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Hospitals
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Military organizations
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:MEDICAL SIMULATION MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America medical simulation market, by product & service
7.2.3.North America medical simulation market, by fidelity
7.2.4.North America medical simulation market, by end user
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.U.S. medical simulation market, by product & service
7.2.5.1.2.U.S. medical simulation market, by fidelity
7.2.5.1.3.U.S. medical simulation market, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada medical simulation market, by product & service
7.2.5.2.2.Canada medical simulation market, by fidelity
7.2.5.2.3.Canada medical simulation market, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico medical simulation market, by product & service
7.2.5.3.2.Mexico medical simulation market, by fidelity
7.2.5.3.3.Mexico medical simulation market, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe medical simulation market, by product & service
7.3.3.Europe medical simulation market, by fidelity
7.3.4.Europe medical simulation market, by end user
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Germany medical simulation market, by product & service
7.3.5.1.2.Germany medical simulation market, by fidelity
7.3.5.1.3.Germany medical simulation market, by end user
7.3.5.2.France
7.3.5.2.1.France medical simulation market, by product & service
7.3.5.2.2.France medical simulation market, by fidelity
7.3.5.2.3.France medical simulation market, by end user
7.3.5.3.UK
7.3.5.3.1.UK medical simulation market, by product & service
7.3.5.3.2.UK medical simulation market, by fidelity
7.3.5.3.3.UK medical simulation market, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy medical simulation market, by product & service
7.3.5.4.2.Italy medical simulation market, by fidelity
7.3.5.4.3.Italy medical simulation market, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain medical simulation market, by product & service
7.3.5.5.2.Spain medical simulation market, by fidelity
7.3.5.5.3.Spain medical simulation market, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe medical simulation market, by product & service
7.3.5.6.2.Rest of Europe medical simulation market, by fidelity
7.3.5.6.3.Rest of Europe medical simulation market, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific medical simulation market, by product & service
7.4.3.Asia-Pacific medical simulation market, by fidelity
7.4.4.Asia-Pacific medical simulation market, by end user
7.4.5.Market size and forecast, by country
7.4.5.1.Japan
7.4.5.1.1.Japan medical simulation market, by product & service
7.4.5.1.2.Japan medical simulation market, by fidelity
7.4.5.1.3.Japan medical simulation market, by end user
7.4.5.2.China
7.4.5.2.1.China medical simulation market, by product & service
7.4.5.2.2.China medical simulation market, by fidelity
7.4.5.2.3.China medical simulation market, by end user
7.4.5.3.Australia
7.4.5.3.1.Australia medical simulation market, by product & service
7.4.5.3.2.Australia medical simulation market, by fidelity
7.4.5.3.3.Australia medical simulation market, by end user
7.4.5.4.India
7.4.5.4.1.India medical simulation market, by product & service
7.4.5.4.2.India medical simulation market, by fidelity
7.4.5.4.3.India medical simulation market, by end user
7.4.5.5.Rest of Asia-Pacific
7.4.5.5.1.Rest of Asia-Pacific medical simulation market, by product & service
7.4.5.5.2.Rest of Asia-Pacific medical simulation market, by fidelity
7.4.5.5.3.Rest of Asia-Pacific medical simulation market, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA medical simulation market, by product & service
7.5.3.LAMEA medical simulation market, by fidelity
7.5.4.LAMEA medical simulation market, by end user
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil
7.5.5.1.1.Brazil medical simulation market, by product & service
7.5.5.1.2.Brazil medical simulation market, by fidelity
7.5.5.1.3.Brazil medical simulation market, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia medical simulation market, by product & service
7.5.5.2.2.Saudi Arabia medical simulation market, by fidelity
7.5.5.2.3.Saudi Arabia medical simulation market, by end user
7.5.5.3.South Africa
7.5.5.3.1.South Africa medical simulation market, by product & service
7.5.5.3.2.South Africa medical simulation market, by fidelity
7.5.5.3.3.South Africa medical simulation market, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA medical simulation market, by product & service
7.5.5.4.2.Rest of LAMEA medical simulation market, by fidelity
7.5.5.4.3.Rest of LAMEA medical simulation market, by end user
CHAPTER 8:COMPANY PROFILES
8.1.CAE INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.GAUMARD SCIENTIFIC COMPANY
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.3.INTELLIGENT ULTRASOUND GROUP PLC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.KYOTO KAGAKU CO. LTD.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.LAERDAL MEDICAL AS
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments
8.6.LIMBS AND THINGS LTD.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments
8.7.MENTICE AB
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.OPERATIVE EXPERIENCE, INC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segment
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments
8.9.SIMULAB CORPORATION
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments
8.10.VIRTAMED AG
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segment
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCTS & SERVICES, 2020–2030 ($MILLION)
TABLE 02.MEDICAL SIMULATION MARKET FOR MODEL-BASED SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.GLOBAL MODEL-BASED SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 04.GLOBAL PATIENT SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 05.GLOBAL MANIKIN-BASED SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 06.GLOBAL SURGICAL SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 07.GLOBAL ULTRASOUND SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 08.MEDICAL SIMULATION MARKET FOR WEB-BASED SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09.GLOBAL WEB-BASED MEDICAL SIMULATION MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 10.GLOBAL SIMULATION SOFTWARE MARKET, 2020–2030 ($MILLION)
TABLE 11.GLOBAL PERFORMANCE RECORDING SOFTWARE MARKET, 2020–2030 ($MILLION)
TABLE 12.GLOBAL VIRTUAL TUTORS MARKET, 2020–2030 ($MILLION)
TABLE 13.GLOBAL LEARNING MANAGEMENT SOFTWARE MARKET, 2020–2030 ($MILLION)
TABLE 14.MEDICAL SIMULATION MARKET FOR SIMULATION TRAINING SERVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15.GLOBAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 16.GLOBAL VENDOR-BASED TRAINING MARKET, 2020–2030 ($MILLION)
TABLE 17.GLOBAL CUSTOM CONSULTING SERVICES MARKET, 2020–2030 ($MILLION)
TABLE 18.GLOBAL EDUCATIONAL SOCIETIES MARKET, 2020–2030 ($MILLION)
TABLE 19.GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY, 2020–2030 ($MILLION)
TABLE 20.GLOBAL MEDICAL SIMULATION MARKET FOR LOW-FIDELITY, BY REGION, 2020–2030($MILLION)
TABLE 21.GLOBAL MEDICAL SIMULATION MARKET FOR MEDIUM-FIDELITY, BY REGION, 2020–2030($MILLION)
TABLE 22.GLOBAL MEDICAL SIMULATION MARKET FOR HIGH-FIDELITY, BY REGION, 2020–2030 ($MILLION)
TABLE 23.GLOBAL MEDICAL SIMULATION MARKET, BY END USER 2020–2030 ($MILLION)
TABLE 24.GLOBAL MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 2020–2030 ($MILLION)
TABLE 25.GLOBAL MEDICAL SIMULATION MARKET FOR HOSPITALS, BY REGION, 2020–2030($MILLION)
TABLE 26.GLOBAL MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY REGION, 2020–2030($MILLION)
TABLE 27.MEDICAL SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 28.NORTH AMERICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 29.NORTH AMERICA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 30.NORTH AMERICA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.NORTH AMERICA MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.U.S. MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 33.U.S. MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 34.U.S. MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35.CANADA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 36.CANADA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 37.CANADA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.MEXICO MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 39.MEXICO MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 40.MEXICO MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41.EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 42.EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 43.EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.EUROPE MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 45.GERMANY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 46.GERMANY MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 47.GERMANY MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48.FRANCE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 49.FRANCE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 50.FRANCE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 51.UK MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 52.UK MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 53.UK MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 54.ITALY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 55.ITALY MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 56.ITALY MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57.SPAIN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 58.SPAIN MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 59.SPAIN MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60.REST OF EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 61.REST OF EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 62.REST OF EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 64.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 65.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 67.JAPAN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 68.JAPAN MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 69.JAPAN MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 70.CHINA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 71.CHINA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 72.CHINA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 73.AUSTRALIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 74.AUSTRALIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 75.AUSTRALIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 76.INDIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 77.INDIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 78.INDIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 80.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 81.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82.LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 83.LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 84.LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85.LAMEA MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 86.BRAZIL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 87.BRAZIL MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 88.BRAZIL MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 89.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 90.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 91.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 92.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 93.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 94.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 95.REST OF LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 96.REST OF LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 97.REST OF LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 98.CAE: COMPANY SNAPSHOT
TABLE 99.CAE: OPERATING SEGMENTS
TABLE 100.CAE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 101.CAE: KEY DEVELOPMENTS
TABLE 102.GAUMARD: COMPANY SNAPSHOT
TABLE 103.GAUMARD: OPERATING SEGMENTS
TABLE 104.GAUMARD: PRODUCT PORTFOLIO
TABLE 105.GAUMARD: KEY DEVELOPMENTS
TABLE 106.INTELLIGENT: COMPANY SNAPSHOT
TABLE 107.INTELLIGENT: OPERATING SEGMENTS
TABLE 108.INTELLIEGENT: PRODUCT PORTFOLIO
TABLE 109.INTELLIGENT: KEY DEVELOPMENTS
TABLE 110.KYOTO KAGAKU: COMPANY SNAPSHOT
TABLE 111.KYOTO KAGAKU: OPERATING SEGMENTS
TABLE 112.KYOTO KAGAKU: PRODUCT PORTFOLIO
TABLE 113.LAERDAL: COMPANY SNAPSHOT
TABLE 114.LAERDAL: OPERATING SEGMENTS
TABLE 115.LAERDAL: PRODUCT PORTFOLIO
TABLE 116.LAERDAL: KEY DEVELOPMENTS
TABLE 117.LIMBS & THINGS: COMPANY SNAPSHOT
TABLE 118.LIMBS & THINGS: OPERATING SEGMENTS
TABLE 119.LIMBS & THINGS: PRODUCT PORTFOLIO
TABLE 120.LIMBS & THINGS: KEY DEVELOPMENTS
TABLE 121.MENTICE: COMPANY SNAPSHOT
TABLE 122.MENTICE: OPERATING SEGMENTS
TABLE 123.MENTICE: PRODUCT PORTFOLIO
TABLE 124.MENTICE: KEY DEVELOPMENTS
TABLE 125.OPERATIVE: COMPANY SNAPSHOT
TABLE 126.OPERATIVE: OPERATING SEGMENTS
TABLE 127.OPERATIVE: PRODUCT PORTFOLIO
TABLE 128.OPERATIVE: KEY DEVELOPMENTS
TABLE 129.SIMULAB: COMPANY SNAPSHOT
TABLE 130.SIMULAB: OPERATING SEGMENTS
TABLE 131.SIMULAB: PRODUCT PORTFOLIO
TABLE 132.SIMULAB: KEY DEVELOPMENTS
TABLE 133.VIRTAMED: COMPANY SNAPSHOT
TABLE 134.VIRTAMED: OPERATING SEGMENTS
TABLE 135.VIRTAMED: PRODUCT PORTFOLIO
TABLE 136.VIRTAMED: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.MEDICAL SIMULATION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF MODEL-BASED SIMULATION MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF WEB-BASED SIMULATION MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF SIMULATION TRAINING SERVICES MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF LOW FIDELITY, BY COUNTRY, 2020-2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF MEDIUM-FIDELITY, BY COUNTRY, 2020-2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF HIGH FIDELITY, BY COUNTRY, 2020-2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2020-2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY COUNTRY, 2020-2030 (%)
FIGURE 22.CAE: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.CAE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 24.CAE: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 25.INTELLIGENT: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.INTELLIGENT: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 27.INTELLIGENT: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 28.MENTICE: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.MENTICE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 30.MENTICE: REVENUE SHARE, BY REGION, 2020 (%)
This section provides the opinions of the top level CXOs in the global medical simulation market. According to the insights of CXOs, increase in use of augmented reality (AR) and virtual reality (VR) techniques, rise in patient safety outcomes, benefits of simulation, and development of new technology, are all expected to significantly boost the growth of the medical simulation market.
The CXOs further added that owing to increase in mortality rates worldwide from medical errors in healthcare facilities including hospitals also drives the market. Furthermore, benefits associated with medical simulation such as training healthcare professionals about normal and complex medical cases are expected to boost the adoption of medical simulation devices. Integration of augmented and virtual reality in medical simulation provides healthcare professionals a real time experience, which boosts the adoption of medical simulation based on virtual reality. Moreover, rise in demand for improved patient safety outcomes is expected to boost the market growth. However, high set-up cost of simulation and other related costs are expected to impede the market growth.
In addition, rise in need for medical students to use the simulation to sharpen their clinical and critical thinking abilities for high-risk situations, student knowledge, confidence in performance, ability in nursing practice, and for satisfaction with learning techniques is anticipated to further drive the growth of the medical simulation market.
The market gains interest of healthcare companies, owing to increase in focus in adoption of medical simulation in hospitals, academic institutions & research centers, and military organizations providing simulations for better patient safety, is a great opportunity for the key players to invest, thus further propelling the growth of the market.
North America is expected to witness highest growth, in terms of revenue, owing to firmly established distribution channel, increase in adoption of advanced technologies such as V-R, rise in medical errors, presence of key players, and advancements in healthcare investments. Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to the number of hospitals, commercialization, and innovation in simulator, rise in R & D activities, and increase in awareness in healthcare sectors. However, high cost of the implementation and stringent government policies are projected to restrain the market growth during the forecast period.
A. The total market value of medical simulation market is $1,687.5 million in 2020.
A. The forecast period for medical simulation market is 2021 to 2030
A. The market value of medical simulation market in 2021 is $1,940.00 million.
A. The base year is 2020 in medical simulation market
A. Top companies such as CAE, Inc., Gaumard Scientific Company, Inc., Intelligent Ultrasound Group Plc., Kyoto Kagaku Co. Ltd., Laerdal Medical AS, Limbs and Things, Ltd., Mentice AB, Operative Experience, Inc., Simulab Corporation and VirtaMed AG held a high market position in 2020.
A. Model-based segment dominated the global market in 2020, and expected to continue this trend throughout the forecast period due to the rise in patient safety, limited access to live patients is expected to drive the segment
A. Increase in minimally invasive surgeries, rise in patient care safety, limited access to live patients and investments in healthcareis anticipated to drive the market in the forecast period.
A. North America is projected to account for a major share of the global medical simulation market during the forecast period. U.S. dominated the North America medical simulation market owing to rise in medical errors, research and development for new technology for practising complex as well as regular surgeries before actually performing them and rise in investments in healthcare sector due to presence of key players across the country.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
